Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 18, 2026, Dean A. Foate, Chair of the Board of Directors (the “Board”) of Plexus Corp.…
Filed Nov 19, 2026Accepted Nov 19, 2026, 4:28 PM ESTCIK 785786Accession 0000785786-26-000068
At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 18, 2026, Dean A. Foate, Chair of the Board of Directors (the “Board”) of Plexus Corp. (the “Company”), notified the Company of his decision not to stand for reelection to the Board at the Company’s 2027 Annual Meeting of Shareholders (the “2027 Annual Meeting”). Mr. Foate will continue to serve as a director and Chair of the Board until the conclusion of the 2027 Annual Meeting, at which time his service on the Board will end. Mr. Foate’s decision is a personal one and is not the result of any disagreement with the Company, its management or the Board on any matter relating to the Company’s operations, policies or practices.
The Board has selected Michael V. Schrock, a current member of the Board, to succeed Mr. Foate as Chair of the Board, effective upon the conclusion of the 2027 Annual Meeting, subject to Michael V. Schrock’s reelection to the Board by the Company’s shareholders at the 2027 Annual Meeting.
In connection with Mr. Foate’s decision not to stand for reelection, the Board has approved a reduction in the size of the Board from ten to nine directors, effective as of the conclusion of the 2027 Annual Meeting.
The Board thanks Mr. Foate for his many years of dedicated service and leadership to the Company, including as Chief Executive Officer and, subsequently, as a director and Chair of the Board.